Jpmorgan Chase & Co »

Definium Therape shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Definium Therape (DFTX) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Definium Therape

Tip: Access up to 7 years of quarterly data

All positions including Definium Therape held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Definium Therape by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2026-06-30 $12M 266k 46.55
2026-03-31 $4.6M 265k 17.50

More positions owned by Jpmorgan Chase & Co

Nvidia Corporation Common (NVDA)
Apple Common (AAPL)
Microsoft Corp Common (MSFT)
Alphabet Common (GOOG)
Amazon Common (AMZN)
Broadcom Common (AVGO)
State Street Spdr S&p 500 Etf Fund (SPY)
Alphabet Common (GOOGL)
Micron Technology Common (MU)
Meta Platforms Common (META)
Advanced Micro Devices Common (AMD)
Lam Research Corp Common (LRCX)
Tesla Common (TSLA)
Vanguard S&p 500 Etf Fund (VOO)
Eli Lilly & Co Common (LLY)

View all positions for Jpmorgan Chase & Co

Top funds holding Definium Therape

BlackRock
venBio Select Advisor
Driehaus Capital Management
Jupiter Topco
FMR
Geode Capital Management
Henderson Group
Capital Research and Management Company - Division 3
Octagon Capital Advisors
Wellington Management Company
Deep Track Capital
State Street Corporation
Citadel Advisors
Commodore Capital
Susquehanna International

View all funds holding Definium Therape